Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data

Publisher： Karger

E-ISSN： 1660-3818|43|5|365-374

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.43, Iss.5, 2016-08, pp. : 365-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3727-3736

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review

By  

Current Drug Safety, Vol. 10, Iss. 3, 2015-01 ,pp. : 234-250

Bentham Science Publishers

Access to resources Recommend Favorite

Are Sham Acupuncture Interventions More Effective than (Other) Placebos? A Re-Analysis of Data from the Cochrane Review on Placebo Effects

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 17, Iss. 5, 2010-09 ,pp. : 259-264

Karger

Access to resources Recommend Favorite

Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy

By Winstedt Dag   Hanna Jennifer   Schött Ulf  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 2, 2013-03 ,pp. : 161-169

Informa Healthcare

Access to resources Recommend Favorite

Dialysis Survivors: Clinical Status of Patients on Treatment for More than 10 Years

By  

Nephron Clin Pract, Vol. 108, Iss. 3, 2008-03 ,pp. : c207-c212

Karger

Access to resources Recommend Favorite